Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Immunome Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 29 | 26 | −3 |
| Shares | 2.69M | 2.41M | −288.0K (−10.7%) |
| Value | $15.4M | $7.78M | −$7.65M (−49.6%) |
New holders (4)
Institutions that held Immunome Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 13,159 | $42.0K | 0.00% |
| Titleist Asset Management, Ltd. | 10,000 | $32.0K | 0.01% |
| Simplex Trading, LLC | 1,963 | $6.00K | 0.00% |
| Group One Trading, L.P. | 48 | $0 | 0.00% |
Sold out (7)
Institutions that held Immunome Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Atom Investors LP | 39,770 | $226.0K |
| Ridgewood Investments LLC | 28,013 | $159.0K |
| Wetherby Asset Management Inc | 17,881 | $102.0K |
| First Republic Investment Management, Inc. | 15,270 | $87.0K |
| ETF Managers Group, LLC | 3,670 | $20.0K |
| Massmutual Trust Co FSB | 514 | $3.00K |
| Rockefeller Capital Management L.P. | 20 | $0 |